Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Amgen (NQ: AMGN )

227.81 USD +0.08 (+0.04%)
Official Closing Price Updated: 7:43 PM EST, Mar 8, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Amgen

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
The Daily Biotech Pulse: Fulgent's Big Quarter, Gilead Awaits FDA Decision, Apellis Winds Up COVID-19 Study
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags SANA BCLI APLS
From Benzinga
10 Biggest Price Target Changes For Friday
SVB Leerink raised Amgen Inc. (NASDAQ: AMGN) price target from $252 to $260. Amgen shares fell 0.9% to close at $221.91 on ... 
Tags AMGN Benzinga PRPL
From Benzinga
Amgen Becomes Oversold (AMGN)
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a... 
Tags Stocks
From Market News Video
SHAREHOLDER ALERT: WeissLaw LLP Investigates Five Prime Therapeutics, Inc.
WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Five Prime Therapeutics, Inc. ("Five Prime" or the "Company") (NASDAQ: FPRX)... 
From PR Newswire
Amgen to Buy Oncology Start-Up Five Prime Therapeutics for $1.9 Billion
The big biotech wants to bolster its late-stage pipeline with a potential new stomach cancer treatment. 
Tags FPRX Market News AMGN
From Motley Fool
Stocks Mixed Ahead of Powell's Bond Yields Update
Better-than-expected jobs data is giving sentiment a lift. 
Tags Market News Stocks / Equities
From Blogs - TalkMarkets
FIVE PRIME ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of FPRX and Encourages Investors to Contact the Firm
From GlobeNewswire News Releases
Why Five Prime Therapeutics Stock Is Skyrocketing Today
Amgen is paying a premium to buy the small biotech. 
Tags AMGN Market News FPRX
From Motley Fool
FPRX Stock: The Huge Takeover News That Has Five Prime Therapeutics Shares Blasting Higher
<p><a rel="nofollow" href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice & Trading Tips</a></p> <p>Five Prime Therapeutics (FPRX) stock is soaring higher on Thursday... 
Tags FPRX Today's Market NASDAQ:FPRX,NASDAQ:AMGN
From InvestorPlace
Amgen Pays $1.9B For Five Prime Therapeutics Acquisition
Amgen Inc(NASDAQ:AMGN)has agreed to acquireFive Prime Therapeutics Inc(NASDAQ:FPRX) for $38 per ... 
Tags News Biotech Health Care
From Benzinga
Five Prime Therapeutics Stock Rockets On Amgen's $1.9 Billion Takeover
Amgen said Thursday it will spend $1.9 billion to buy Five Prime Therapeutics, a small biotech company with a promising stomach cancer drug. The news sent FPRX stock rocketing. 
From Investor's Business Daily
Amgen to Acquire Five Prime Therapeutics for $1.9 Billion in Cash
AMGEN TO ACQUIRE FIVE PRIME THERAPEUTICS FOR $1.9 BILLION IN CASH 
From Business Wire News Releases
Amgen To Acquire Five Prime Therapeutics For $1.9 Billion in Cash
Acquisition Includes Bemarituzumab, A Phase 3 Ready, First-In-Class Program For Gastric Cancer, the Third Leading Cause of Cancer Mortality Worldwide 
From PR Newswire
Amgen Announces 2021 Second Quarter Dividend
Amgen (NASDAQ:AMGN) today announced that its Board of Directors declared a $1.76 per share dividend for the second quarter of 2021. The dividend will be paid on June 8, 2021, to all stockholders of... 
From PR Newswire
Is It Time to Buy the Dow Jones' 3 Worst-Performing February Stocks?
Shares of Apple, Walmart, and Amgen didn't stumble for the reason most stocks usually sell off. 
Tags WMT BRK/B AMGN
From Motley Fool
The Daily Biotech Pulse: KemPharm ADHD Drug Gets The Nod, MediciNova Shelves Vaccine Study
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags M&A ITOS Market News
From Benzinga
BLINCYTO® (Blinatumomab) Demonstrated Significantly Prolonged Event-Free Survival Compared With Consolidation Chemotherapy In Pediatric Patients With Relapsed Acute Lymphoblastic Leukemia
Phase 3 Results Published in The Journal of The American Medical Association 
From PR Newswire
DIA, GS, AMGN, BA: Large Outflows Detected at ETF
Symbols mentioned in this story: DIA, GS, AMGN, BA Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These ''units''... 
Tags ETFs
From ETF Channel
Where Will Pfizer Be in 1 Year?
The company will face competition on many fronts before 2022 arrives. 
Tags PFE MRNA AMGN
From Motley Fool
Is Now the Time to Invest in the Dow Jones?
Check your investment goals and risk tolerance to find the answer. 
Tags XOM HON Market News
From Motley Fool
AstraZeneca/Amgen's Tezepelumab Reduces Asthma Exacerbations, Phase 3 Trial Shows
AstraZeneca Plc(NASDAQ:AZN) and its partnerAmgen Inc(NASDAQ:AMGN) haveannounced positive ... 
Tags AMGN Benzinga General
From Benzinga
Tezepelumab Is The First Biologic To Significantly Reduce Exacerbations In Broad Population Of Patients With Severe, Uncontrolled Asthma
Data From Investigational Therapy Tezepelumab Phase 3 NAVIGATOR Trial in Patients With Severe Asthma Presented at the American Academy of Asthma Allergy & Immunology Annual Meeting 
From PR Newswire
The Daily Biotech Pulse: Adcom Test Awaits J&J's COVID-19 Vaccine, Lilly To Supply Additional Antibody Therapy Doses To US, Regulatory Setback For Tricida
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags MRK ORGO DRNA
From Benzinga
Moderna Reports Fourth Quarter and Fiscal Year 2020 Financial Results and Provides Business Updates
Moderna reports fourth quarter and fiscal year 2020 financial results and provides business updates. 
From Business Wire News Releases
Amgen To Present At The Cowen 41st Annual Healthcare Conference
Amgen (NASDAQ:AMGN) will present at the Cowen 41st Annual Virtual Healthcare Conference at 12:50 p.m. ET on Thursday, March 4, 2021. Murdo Gordon, executive vice president of Global Commercial... 
From PR Newswire
Why Turning Point Is Turning Heads
This oncology biotech is up over 450% since its April 2019 IPO. Are there still gains to come, or should investors turn away? 
Tags TPTX AMGN PFE
From Motley Fool
2 Best Pharma Stocks to Buy Right Now
These under-appreciated pharma stocks have the potential to become long-term winners. 
Tags Market News MYL ABBV
From Motley Fool
Amgen To Webcast Investor Meeting At AAAAI Virtual Annual Meeting
Amgen (NASDAQ:AMGN) will host a webcast call for the investment community in conjunction with the 2021 American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting on Friday, Feb. 26, at... 
From PR Newswire
How Does Amgen's Debt Look?
Over the past three months, shares of Amgen (NASDAQ:AMGN) rose by 2.58%. Before we understand the importance of debt, let us ... 
Tags BZI/Debt News Markets
From Benzinga
Amgen Submits Supplemental New Drug Application for Otezla® (apremilast) for Adults with Mild-To-Moderate Plaque Psoriasis
Filing Based on Data From Phase 3 ADVANCE Study 
From PR Newswire
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.